Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVAS: EPA for Cerebral Vasospasm
NCT00839449Phase 4Completed
- Sponsor
- Yamaguchi University Hospital
- Start
- Dec 2004
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid in cerebral vasospasm, sponsored by Yamaguchi University Hospital. Started Dec 2004; status: completed.
02
Drugs
eicosapentaenoic acid
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT00839449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00839449.